Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Wang, Xin ^a   Cao, Yuzhen ^b   Fu, Yunwei ^b   Guo, Guifang ^c   Zhang, Xiuying ^b  

^a HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY   (China)

^b NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^c China Institute of Veterinary Drugs Control   (China)

Author keywords

Carbon tetrachloride; Fatty acid; High fat feed; Mouse; Nonalcoholic fatty liver disease

Indexed keywords

CARBON TETRACHLORIDE; FATTY ACID; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; VEGETABLE OIL; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HISTOPATHOLOGY; LIPID DIET; MALE; MASS SPECTROMETRY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; SERODIAGNOSIS; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; FATTY LIVER; LIVER; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; CARBON TETRACHLORIDE; DIET, HIGH-FAT; FATTY ACIDS; FATTY LIVER; LIPIDS; LIVER; MALE; MICE; MICE, INBRED C57BL;

EID: 83355164477     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-234     Document Type: Article

References (37)

1. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease(NAFLD). Musso G, Gambino R, Cassader M, Prog Lipid Res 2009 48 1 26
2. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Gastroenterology 2001 120 1183 1192 (Pubitemid 32246672)
3. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Chitturi S, Abeygunasekera S, Farrell GC, Hepatology 2002 35 373 379 (Pubitemid 34106377)
4. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Pinto HC, Baptista A, Camilo ME, Valente A, Sargoca A, Moura MC, Digest Dis Sci 1996 41 172 179 (Pubitemid 26064854)
5. Non-alcoholic steatohepatitis. Jansen PL, Eur J Gastroen Hepat 2004 16 1079 1085 (Pubitemid 39488776)
6. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ, J Clin Invest 2005 115 1343 1351 (Pubitemid 40629054)
7. Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. Goldberg IJ, Ginsberg HN, Gastroenterology 2006 130 1343 1346
8. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholicfatty liver disease. Videla LA, Rodrigo R, Araya J, Poniachik J, Free Radic Biol Med 2004 37 1499 1507 (Pubitemid 39349251)
9. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Araya J, Rodrigo R, Videla LA, Clin Sci 2004 106 635 643 (Pubitemid 38797577)
10. Fatty acid composition of liver total lipids in alcoholic patients with and without liver damage. De la Maza MP, Hirsch S, Nieto S, Petermann M, Bunout D, Alcohol Clin Exp Res 1996 20 1418 1422 (Pubitemid 26393944)
11. Hepatic free fatty acids in alcoholic liver disease and morbid obesity. Mavrelis PG, Ammon HV, Gleysteen JJ, Komorowski RA, Charaf UK, Hepatology 1983 3 226 231 (Pubitemid 13165374)
12. Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. De Almeida IT, Cortez-Pinto H, Fidalgo G, Rodrigues D, Camilo ME, Clin Nutr 2002 21 219 223 (Pubitemid 34846801)
13. A lipidomic analysis of nonalcoholic fatty liver disease. Puri P, Baillie RA, Wiest MM, Hepatology 2007 46 1081 1090 (Pubitemid 350144772)
14. Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt-and high- fat diet-induced hypercholesterolemia in mice. Pan SY, Yang R, Dong H, Yub ZL, Ko KM, Eur J Pharmacol 2006 552 170 175 (Pubitemid 44648081)
15. Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and nonalcoholic fatty liver disease. Das SK, Balakrishnan V, Mukherjee S, Vasudevan DM, Scand J Clin Lab Inv 2008 68 323 334 (Pubitemid 351962413)
16. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Anstee QM, Goldin RD, Int J Exp Pathol 2006 87 1 16
17. Low n-6: n-3 fatty acid ratio, with fish- or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice. Riediger ND, Othman R, Fitz E, Pierce GN, Suh M, Moghadasian MH, Eur J Nutr 2008 47 153 160
18. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Farrell GC, Larter CZ, Hepatology 2006 43 99 112
19. Hepatotoxicity and mechanism of haloalkane: carbon tetrachloride as a toxicological model. Weber LWD, Boll M, Stampl A, Crit Rev Toxicol 2003 33 105 136 (Pubitemid 36432872)
20. Role of lipid peroxidation in non-alcoholic steatoheaptitis. Fraenkel E, Lazurova I, Feher J, Orv Hetil 2004 145 611 618
21. Re-evaluation of fatty acid metabolism- related gene expression in nonalcoholic fatty liver disease. Kohjima M, Enjoji M, Higuchi N, Int J Mol Med 2007 20 351 358
22. Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis. Barreyro FJ, Kobayashi S, Bronk SF, Werneburg NW, Malhi H, Gores GJ, J Biol Chem 2007 282 27141 27154 (Pubitemid 47501972)
23. Nutritional and hormonal factors influencing desaturation of essential fatty acids. Brenner RR, Prog Lipid Res 1981 20 41 47
24. The influence of trans-acids on desaturation and elongation of fatty acids in developing brain. Cook HW, Lipids 1981 16 920 926
25. Effects of dietary polyunsaturated fatty acids and nucleotides on tissue fatty acid profiles of rat with carbon techachloride-induced liver damage. Fontana L, Moreira E, Torres MI, Periago JL, Sanchez de Medina F, Gil A, Clin Nutr 1999 18 93 101 (Pubitemid 29237909)
26. Endogenous functions of aryl hydrocarbon receptor(AHR): intersection of cytochrome P450-1(CYP1)-metabolized eisocanoids and AHR biology. Nebert DW, Karp CL, J Biol Chem 2008 283 36061 36065
27. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcohoic fatty liver disease: a pilot study. Capanni M, Calella F, Biagini MR, Aliment Pharm Therap 2006 23 1143 1151 (Pubitemid 43779354)
28. Essential fatty acids: Biochemistry, Physiological and Pathology. Das UN, Biotechnol J 2006 1 420 439
29. Dietary n-3 polyunsaturated fatty acid decrease hepatic triglycerides in fischer 344 rats. Levy JR, Clore JN, Stevens W, Hepatology 2004 39 608 616 (Pubitemid 38337640)
30. Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions. Di Marzo V, Prostag Leukotr Ess 1995 53 239 254
31. Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum. Schievella AR, Regier MK, Smith WL, Lin LL, J Biol Chem 1995 270 30749 30754 (Pubitemid 26005142)
32. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Simopoulos AP, Biomed Pharmacother 2006 60 502 507 (Pubitemid 44635081)
33. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man:possible role in microvesicular steatosis induced by this antibiotics. Fréneaux E, Labbe G, Letteron P, Hepatology 1988 8 1056 1062
34. Effects of various tetracycline derivatives on in vitro and in vivo beta-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides and mortality in mice. Labbe G, Fromenty B, Freneaux E, Biochem Pharmacol 1991 41 638 641
35. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Dixon JB, Bhathal PS, Hughes NR, O'Brien PE, Hepatology 2004 39 1647 1654 (Pubitemid 38702666)
36. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Kleiner DE, Brunt EM, Natta MV, Hepatology 2005 41 1313 1321 (Pubitemid 40770284)
37. A simple method for the isolation and purification of total lipides from animal tissues. Foleh J, Lees M, Sloame Stanley GH, J Biol Chem 1957 226 497 509